Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(3):329–339. doi: 10.1111/j.1750-3639.2003.tb00032.x

Quantifying the Early Stages of Remyelination Following Cuprizone‐induced Demyelination

Mark F Stidworthy 1, Stephane Genoud 2, Ueli Suter 2, Ned Mantei 2, Robin J M Franklin 1,✉
PMCID: PMC8095752  PMID: 12946022

Abstract

The demyelinating toxin cuprizone is used increasingly in mouse studies of central nervous system remyelination. The value of this model for such studies depends on an accurate description of its quantifiable features. We therefore investigated histology and ultrastructure during the early oligodendrocyte differentiation phase of remyelination in mice given cuprizone and allowed to recover for 2 weeks. Limiting the dose of cuprizone to 0.2% overcame significant mouse morbidity and weight loss seen with a 0.4% dose, but the distribution of cuprizone‐induced demyelination was anatomically variable. The caudal corpus callosum and dorsal hippocampal commissure mostly demyelinated at this dose, but the rostral corpus callosum and rostral cerebellar peduncles did not. This variable response, together with small axon diameters and hence thin myelin sheaths, hindered analysis of the progress of early remyelination. The proportion of myelinated and unmyelinated axons in defined regions followed expected trends, but there was pronounced variation between animals. Furthermore, group mean G ratios did not change as expected during the early stages of remyelination, and regression analysis revealed a complex relationship between axon diameter and myelin sheath thickness during this period. We also noted axonal pathology that persisted for at least 2 weeks after cuprizone withdrawal.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

References

  • 1. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC (2002) Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22:8574–8585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Arnett HA, Hellendall RP, Matsushima GK, Suzuki K, Laubach VE, Sherman P, Ting JP (2002) The protective role of nitric oxide in a neurotoxicant‐induced demyelinating model. J Immunol 168:427–433. [DOI] [PubMed] [Google Scholar]
  • 3. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP (2001) TNFalpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116–1122. [DOI] [PubMed] [Google Scholar]
  • 4. Blakemore WF (1973) Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J Neurol Sci 20:63–72. [DOI] [PubMed] [Google Scholar]
  • 5. Blakemore WF (1973) Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone. J Neurol Sci 20:73–83. [DOI] [PubMed] [Google Scholar]
  • 6. Blakemore WF (1974) Remyelination of the superior cerebellar peduncle in old mice following demyelination induced by cuprizone. J Neurol Sci 22:121–126. [DOI] [PubMed] [Google Scholar]
  • 7. Carlton WW (1967) Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity. Life Sci 6:11–19. [DOI] [PubMed] [Google Scholar]
  • 8. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD (2000) NG2‐positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404–6412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Chang A, Tourtellotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165–173. [DOI] [PubMed] [Google Scholar]
  • 10. Elsworth S, Howell JM (1973) Variation in the response of mice to cuprizone. Res Vet Sci 14:385–387. [PubMed] [Google Scholar]
  • 11. Gao X, Gillig TA, Ye P, D'Ercole AJ, Matsushima GK, Popko B (2000) Interferon‐gamma protects against cuprizone‐induced demyelination. Mol Cell Neurosci 16:338–349. [DOI] [PubMed] [Google Scholar]
  • 12. Godlewski A (1991) Morphometry of myelin fibers in corpus callosum and optic nerve of aging rats. J Hirnforsch 32:39–46. [PubMed] [Google Scholar]
  • 13. Gozzo S, Renzi P, D'Udine B (1979) Morphological differences in cerebral cortex and corpus callosum are genetically determined in two different strains of mice. Int J Neurosci 9:91–96. [DOI] [PubMed] [Google Scholar]
  • 14. Hemm RD, Carlton WW, Welser JR (1971) Ultrastructural changes of cuprizone encephalopathy in mice. Toxicol Appl Pharmacol 18:869–882. [DOI] [PubMed] [Google Scholar]
  • 15. Hiremath MM, Saito Y, Knapp GW, Ting JP, Suzuki K, Matsushima GK (1998) Microglial/macrophage accumulation during cuprizone‐induced demyelination in C57BL/6 mice. J Neuroimmunol 92:38–49. [DOI] [PubMed] [Google Scholar]
  • 16. Kesterson JW, Carlton WW (1970) Aqueductal stenosis as the cause of hydrocephalus in mice fed the substituted hydrazine, cuprizone. Exp Mol Pathol 13:281–294. [DOI] [PubMed] [Google Scholar]
  • 17. Ludwin SK (1978) Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab Invest 39:597–612. [PubMed] [Google Scholar]
  • 18. Ludwin SK (1980) Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors. Lab Invest 43:382–387. [PubMed] [Google Scholar]
  • 19. Mason JL, Langaman C, Morell P, Suzuki K, Matsushima GK (2001) Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal caliber. Neuropathol Appl Neurobiol 27:50–58. [DOI] [PubMed] [Google Scholar]
  • 20. Mason JL, Suzuki K, Chaplin DD, Matsushima GK (2001) Interleukin‐1beta promotes repair of the CNS. J Neurosci 21:7046–7052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK (2000) Insulin‐like growth factor‐1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 20:5703–5708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107–116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. McMahon EJ, Cook DN, Suzuki K, Matsushima GK (2001) Absence of macrophage‐inflammatory protein‐1 alpha delays central nervous system demyelination in the presence of an intact blood‐brain barrier. J Immunol 167:2964–2971. [DOI] [PubMed] [Google Scholar]
  • 24. Morell P, Barrett CV, Mason JL, Toews AD, Hostettler JD, Knapp GW, Matsushima GK et al (1998) Gene expression in brain during cuprizone‐induced demyelination and remyelination. Mol Cell Neurosci 12:220–227. [DOI] [PubMed] [Google Scholar]
  • 25. Sturrock RR (1980) Myelination of the mouse corpus callosum. Neuropathol Appl Neurobiol 6:415–420. [DOI] [PubMed] [Google Scholar]
  • 26. Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601–609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Wolswijk G (2002) Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125:338–349. [DOI] [PubMed] [Google Scholar]
  • 28. Woodruff RH, Franklin RJM (1999) Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti‐galactocerebroside: a comparative study. Glia 25:216–228. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES